바로가기메뉴

본문 바로가기 주메뉴 바로가기
 

logo

메뉴

Browse Articles

Is ZNF462 at 9q31.2 a Novel Kallmann Syndrome Gene?
Hyung-Goo Kim ; Soo-Hyun Kim ; Mi-Hyeon Jang ; Lawrence C. Layman pp.1-5 https://doi.org/10.22742/JIG.2026.8.1.1
초록보기
Abstract

ZNF462 haploinsufficiency is the recognized cause of Weiss-Kruszka syndrome, a neurodevelopmental disorder characterized by global developmental delay, craniofacial anomalies, hypotonia, and midline brain defects. So far, ZNF462 has not been implicated in reproductive endocrinology or congenital hypogonadotropic hypogonadism. However, new clinical evidence challenges this view. A Finnish boy reported by Iivonen et al. carried a 9q31.2 microdeletion encompassing ZNF462 and displayed both Weiss-Kruszka syndrome and Kallmann syndrome. Because ZNF462 had not been associated with reproductive phenotypes at the time, the authors proposed that an unknown Kallmann syndrome gene within the deleted interval must explain the endocrine findings. Subsequently, Park et al. described a Korean boy with a truncating ZNF462 variant who exhibited Weiss-Kruszka syndrome together with an empty sella, growth hormone deficiency, and markedly delayed puberty. In this case, isolated ZNF462 loss-of-function variant-without a multigene deletion-should account for the endocrine abnormalities. More recently, Zhou et al. reported a prepubertal Chinese boy harboring a heterozygous truncating ZNF462 variant who presented with bilateral cryptorchidism and complete growth hormone deficiency, further supporting a role for ZNF462 haploinsufficiency in hypothalamic-pituitarygonadal axis dysfunction. Together, these cases provide converging evidence that ZNF462 disruption can affect development and function of the hypothalamic-pituitary-gonadal axis. This mini-review synthesizes current data, explores biological plausibility based on ZNF462 molecular interactions, and discusses how neurodevelopmental disorders and delayed puberty frequently cooccur due to shared developmental pathways. We propose that ZNF462 should now be considered a strong candidate gene for Kallmann syndrome and highlight the need for systematic reanalysis of genomic datasets to define its role more precisely.

Copy number variant analysis in next-generation sequencing panels for germline disorders
초록보기
Abstract

A copy number variant (CNV) analysis is widely performed in next-generation sequencing (NGS) tests for germline disorders, such as NGS panels or whole exome sequencing. The CNVs provide a high proportion of positive results and the frequency of the CNVs varies depending on the NGS panel categories. To provide accurate CNV results from NGS data, we need to select appropriate analysis methods and manage quality control (QC) metrics of NGS testing. This review briefly introduces the CNV analysis methods associated with NGS panels, investigates the frequency of CNVs among the different NGS panel categories, and suggests factors that need to be considered before performing a CNV analysis as part of an NGS test.

Genetics of Thyroid Dyshormonogenesis: From Molecular Mechanisms to Precision Management
초록보기
Abstract

Congenital hypothyroidism (CH) is one of the most common endocrine disorders in newborns and an important preventable cause of intellectual disability. Thyroid dyshormonogenesis accounts for approximately 15%–20% of CH cases and results from defects in thyroid hormone synthesis. Recent advances in molecular genetics have identified several key genes involved in this process, including SLC5A5, TPO, DUOX2, DUOXA2, TG, SLC26A4, and IYD. These genes affect different steps of hormone production, such as iodide transport, organification, thyroglobulin synthesis, and iodide recycling. Clinical presentations vary widely, ranging from transient to permanent hypothyroidism, depending on the type and severity of genetic defects. A precise genetic diagnosis has important clinical implications. It can guide individualized treatment strategies and help predict disease courses, including the likelihood of transient versus permanent hypothyroidism. In addition, early identification of affected family members enables timely intervention and prevention of developmental complications. In conclusion, thyroid dyshormonogenesis represents a genetically heterogeneous group of disorders. Integrating genetic, biochemical, and clinical data is essential for precision management and may improve long-term outcomes in patients with congenital hypothyroidism.

logo